← Alle mensen

FR

Federico Rojo

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Can...

Clinical cancer research : an official journal of the American Association for Cancer Research · 2 maart 2026

FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA...

Clinical cancer research : an official journal of the American Association for Cancer Research · 2 september 2025

Triple-negatief PAM50 non-basaal subtype en capecitabine-voordeel: CREATE-X analyse

Clinical cancer research : an official journal of the American Association for Cancer Research · 17 januari 2023

p27 en cycline D1 expressie en adjuvant trastuzumab-voordeel bij HER2-positief mammacarcinoom

Clinical cancer research : an official journal of the American Association for Cancer Research · 1 juli 2018

MAF-amplificatie en effect van adjuvant zoledroninezuur bij vroeg mammacarcinoom

The Lancet. Oncology · 2017-11